This is a PDF file of a peer-reviewed paper that has been accepted for publication. Although unedited, the content has been subjected to preliminary formatting. Nature is providing this early version of the typeset paper as a service to our authors and readers. The text and figures will undergo copyediting and a proof review before the paper is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers apply.

No abstract

No abstract

Highlights d Healthy gut contains ILC1s, ILC3s, and ILC3/NKs, but no ILC2s d Blood and tumor ILCs from CRC patients have unique transcriptomic features d Tumor tissue from CRC patients contains a tumor specific ILC1-like subset and ILC2s d SLAMF1 is identified as an anti-tumor biomarker in CRC